NTRA Natera, Inc.

NASDAQ
$319.09

Natera, Inc. (NTRA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below NTRA's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 7 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
83 transactions
Purchases
$0
0 shares
Sales
$14.4M
35,974 shares
Net activity
-$14.4M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $14.4M 83 transactions · 35,974 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $1.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Sheena Jonathan 14 fills Director Sell 10b5-1 1,500 $319.30 $478.9K 8,210 −15.4% of holding
Sheena Jonathan 19 fills Director Sell 10b5-1 3,150 $316.00 $995.4K 217,597 −1.4% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 470 $391.49 $184.0K 45,779 −1% of holding
Chapman Steven Leonard 3 fills CEO AND PRESIDENT Sell 10b5-1 3,801 $411.80 $1.6M 91,211 −4% of holding
Moshkevich Solomon 12 fills PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 3,419 $409.77 $1.4M 104,733 −3.2% of holding
Rabinowitz Matthew 2 fills EXECUTIVE CHAIRMAN Sell 10b5-1 748 $400.02 $299.2K 2,117,659 −0% of holding
RABINOWITZ DANIEL 2 fills SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 341 $400.05 $136.4K 168,214 −0.2% of holding
Brophy Michael Burkes 2 fills CHIEF FINANCIAL OFFICER Sell 10b5-1 325 $399.99 $130.0K 46,566 −0.7% of holding
Fesko John 2 fills PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 302 $400.01 $120.8K 195,571 −0.2% of holding
Sheena Jonathan 2 fills Director Sell 10b5-1 112 $399.97 $44.8K 217,683 −0.1% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 1,906 $425.55 $811.1K 46,574 −3.9% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 3,430 $426.34 $1.5M 91,232 −3.6% of holding
Brophy Michael Burkes 3 fills CHIEF FINANCIAL OFFICER Sell 10b5-1 2,376 $426.40 $1.0M 49,658 −4.6% of holding
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 1,162 $426.34 $495.4K 104,742 −1.1% of holding
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 968 $426.34 $412.7K 168,221 −0.6% of holding
Fesko John PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 898 $426.34 $382.9K 195,578 −0.5% of holding
Sheena Jonathan Director Sell 10b5-1 187 $426.34 $79.7K 217,686 −0.1% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 2,264 $406.00 $919.2K 94,662 −2.3% of holding
Rabinowitz Matthew EXECUTIVE CHAIRMAN Sell 10b5-1 1,718 $406.00 $697.5K 2,117,676 −0.1% of holding
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 1,010 $406.00 $410.1K 105,904 −0.9% of holding
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 884 $406.00 $358.9K 169,189 −0.5% of holding
Fesko John PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 781 $406.00 $317.1K 196,476 −0.4% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 781 $406.00 $317.1K 50,856 −1.5% of holding
Sheena Jonathan Director Sell 10b5-1 291 $406.00 $118.1K 217,873 −0.1% of holding
Sheena Jonathan 8 fills Director Sell 10b5-1 3,150 $410.55 $1.3M 221,114 −1.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.